Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Standard BioTools Affirms FY2025 Sales Guidance of $165.00M-$175.00M vs $169.20M Est

Author: Benzinga Newsdesk | May 06, 2025 04:02pm
Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.00 million-$175.00 million to $165.00 million-$175.00 million vs $169.20 million estimate.

Posted In: LAB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist